Skip to main content

AACE Fall Meetings in San Antonio, TX Register Now

  • Diabetes Strategies for Endocrinologists

    CME Credits: 8.5 | MOC Credits: 8.5

    Gain practical applications for persons with diabetes, a growing pandemic in the U.S. and around the world. As the number of people living with diabetes is projected to rise, the need for endocrinologists to keep up with the latest research advancements is essential.

    Engaged: $255, Informed: $340, Non member: $425

  • Exploring CGM - Achieving Treatment Goals Together

    CME Credits: 1 | MOC Credits: 1

    This free online CME/MOC activity takes learners through three case studies of persons with diabetes, addressing the traditional approaches to glucose monitoring, selecting the appropriate Continuous Glucose Monitoring (CGM) device and reviewing clinical management of the person with diabetes.

    Complimentary Activity, FREE

  • AACE's 32nd Annual Meeting - 2023

    CME Credits: | MOC Credits:

    The 2023 AACE Annual Meeting is structured to provide relevant clinical education for practicing endocrinologists, fellows, primary care physicians, physicians assistants, nurse practitioners, nurses, diabetes care and education specialists, clinical pharmacists, registered dietitians, and others

 

Together, We Are AACE

  • ABOUT

  • OUR MISSION

We are a global, inclusive community of endocrine-focused clinical members, affiliates and partners from every walk of professional life. We promote both formal and informal knowledge-sharing through our publications and education- and communication-focused programs. We pride ourselves in offering a uniquely personal experience that gives every member of our community a voice. Learn More

Our mission is elevating the practice of clinical endocrinology to improve global health.Learn More

We are the organization focused on endocrinology, diabetes, and metabolism that is most:

  • Recognized worldwide for its clinical leadership

  • Valued by clinical endocrinologists and other healthcare professionals

  • Trusted by patients

  • Respected by healthcare decision-makers and the public

Learn More

THE LATEST NEWS &
UPDATES

  • Opportunities To Elevate Your Career

    Learn how you can elevate your endocrinology career by participating in AACE consensus statements, guidelines, educational programs, abstracts, and more.

    Volunteer with AACE
  • Federal Policy Update - July 2022

    Read the July 2022 federal policy update to learn about the results of the June 28th House Committee on Energy and Commerce Subcommittee on Oversight and Investigation hearing on “Protecting America's Seniors: Oversight of Private Sector Medicare Advantage Plans."

    Federal Policy Update
  • Federal Policy Update - July 20, 2022

    Read the July 2022 federal policy update to learn about the Centers for Medicare and Medicaid Services (CMS) newly released proposed 2023 Medicare physician fee schedule rule

    Federal Policy Update - July 2022
  • Federal Policy Update

    On May 25, the Senate confirmed Chiquita Brooks-LaSure to be the Centers for Medicare and Medicaid Services Administrator by a vote of 55-44. She was sworn in two days later. In her first interview, Brooks-LaSure stated that her top priorities will be to expand health insurance coverage and address health disparities.

    Federal Policy Update
  • Presenting PrescriptionHelp.aace.com – A directory of endocrine prescription affordability programs

    Presenting PrescriptionHelp.aace.com – A directory of prescription affordability programs and resources for your endocrine patients to help them acquire the medications they need at reduced out-of-pocket costs.

  • In Memoriam: Alan J. Garber, MD, PhD, MACE

    It is with great sadness that I share the news of Dr. Alan Garber’s passing yesterday on April 9, 2020. Dr. Garber was a Charter Member of AACE, as well as a Past President of both AACE and ACE.

  • AACE 2020 Election Results

    We are pleased to report to you the results of the AACE 2020 elections. Dr. Daniel L. Hurley, Chair of the Nominating Committee, thanks the members of the Nominating Committee for their time and effort evaluating a number of excellent candidates for Officer positions and the Board of Directors and for developing a strong slate of candidates for the 2020 election.

    we are aace
  • FDA approves additional doses of Trulicity® (dulaglutide) for the treatment of type 2 diabetes

    The U.S. Food and Drug Administration (FDA) approved two additional doses of Eli Lilly and Company's (NYSE: LLY) Trulicity® (dulaglutide). The approval expands the label of once-weekly Trulicity to include 3.0 mg and 4.5 mg doses based on data from AWARD-11. The phase 3 trial showed the additional doses led to further benefits in A1C and body weight reduction when compared to Trulicity 1.5 mg in people with type 2 diabetes.

  • AACE Position Statement: Coronavirus (COVID-19) and People with Diabetes

    As the coronavirus (COVID-19) continues to spread in the United States, it is important for every

  • Federal Policy Update - December 2021 - January 2022

    On December 3, 2021, President Biden signed the "Further Extending Government Funding Act". Public Law 117-70 funds the Federal government through February 18, 2022. It is likely Congress will again consolidate all the bills into one large appropriations bill. The big question is whether Congress can achieve an agreement on full year appropriations or simply pass another continuing resolution.

    Federal Policy Update - Dec. 2021 - Jan. 2022
  • President Update to AACE Community – January 2022

    AACE leadership spent the last year developing our 2022-2025 strategic plan, and one of our three focus areas is patient and public awareness. AACE President Dr. Felice Caldarella shares how we are further expanding and updating our patient and public resources by featuring “AACE Patient Journeys”, along with other new developments including our involvement in helping to obtain Congressional approval for the National Clinical Care Commission (NCCC) recommendations on diabetes care, and more.

    President Update to AACE Community – January 2022
  • Apply now: Editor-in-Chief Positions for AACE Scientific Journals

    AACE invites nominations and applications for two, separate positions:

  • AACE 2020 Elections: Preliminary Notice of Candidates

    In compliance with the AACE Bylaws, the AACE Nominating Committee is pleased to notify the membership of the selection of the following preliminary slate of candidates for election to Officer positions for a one-year (1) term.

  • Calendar Year (CY) 2022 Medicare Physician Fee Schedule Proposed Rule

    On July 13, 2021, the Centers for Medicare and Medicaid Services (CMS) posted the proposed rule for the 2022 Physician Fee Schedule (PFS) and other Medicare Part B issues. Learn how the results can bring better accessibility, quality, affordability, empowerment, and innovation.

    2022 Medicare Physician Fee Schedule Proposed Rule
  • President/CEO Update to AACE Members – April 2020

    We continue to think of you during this unprecedented season. While over the last several weeks you have received many helpful pieces of guidance, research, and news updates - today we simply wish to remind you that our priority remains to be you: our members. You are the heart of AACE, and you are our foremost thought that guides anything and everything we do.

  • Warning: Recent Uptick in F.A.C.E. Scams

    We have been notified of several fellowship and medical board scams that are targeting physicians by offering a medical certification and/or endocrinology fellowship designation (FACE) from a medical association for a fee.

    scam
  • How AACE is Leading the Way for Clinical Endocrinology

    An update for current AACE members. On October 20, 2020 - we launched a transformed AACE brand and community. While there are a number of changes that were revealed on October 20, here is what you need to know about our direction.

    we are aace
  • FDA Requests Withdrawal of Belviq XR (lorcaserin) from the Market

    Due to signals in safety clinical trials showing possible increased risk of cancer, The U.S. Food and Drug Administration (FDA) requested that the manufacturer of Belviq, Belviq XR (lorcaserin) voluntarily withdraw the weight-loss drug from the U.S. market.

  • U.S. President Takes Action to Lower Drug Prices for Americans

    President Trump signed four executive orders aimed at lowering the prices Americans pay for prescription drugs, including insulin.

  • 2022 Meetings Update from CEO Paul Markowski

    After over a year of producing virtual events during an uncertain time, we are planning for a potential return to in-person events that brings both excitement and new opportunities. As a valued member of our AACE Community, I would like to be transparent with you and share how we are planning a return to in-person conferences in 2022.

    AACE 2022 Events
  • AACE Fall Meetings

    Join AACE in San Antonio, Texas at the beautiful Hyatt Regency San Antonio Riverwalk September 30 - October 2, 2022 for two engaging meetings in one destination. Learn more about our Co-Management Care in Endocrinology meeting and our AACE Cardiometabolic Conference.

    AACE Fall Meetings
  • CDC Prediabetes Test Goal to Increase Public Awareness

    The CDC recently launched in collaboration with Google Health, a prediabetes quiz that will pop up when end users search for certain medical information using their Google browser to bring more public awareness about prediabetes.

  • Federal Policy Update - February 2022

    The current continuing resolution funds the Federal government until February 18, 2022. The House and Senate Appropriations Committees Chairs and Ranking Members continue their negotiations. Learn about the latest updates on the Congressional Budget Office Report, No Surprises Billing Information, President’s Stimulus Bill, and much more.

    Federal Policy Update - February 2022
  • Novel Agent Reduces Bulging Eyes in Thyroid Eye Disease

    The investigational agent teprotumumab was effective for reducing p

  • AACE Position Statement: Coronavirus (COVID-19) Vaccine and the Endocrine Community

    The COVID-19 pandemic entered a new promising phase when the first vaccines for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection became available in late 2020. We at AACE have recommendations for both endocrine patients and care providers.

    covid vaccine
  • Medicare Payment Rules

    On November 2, 2021, the U. S. Department of Health and Human Services Centers for Medicare and Medicaid Services released several final Calendar Year 2022 payment rules. Learn how these rules cover physician fee schedule, hospital outpatient and ambulatory surgical centers, and more.

    Medicare Payment Rules
  • ‘Who, What, Where & Why’ with AACE International Clinician Award Recipient

    In a recent interview with the AACE2019News.com, Yulino Castillo Núñez, MD, recipient of the 2019 AACE International Clinician Award, discussed some of the greatest influences on his career in endocrinology.

COMMUNITY
PERSPECTIVES

I am proud to be an AACE member and to witness the continued growth of this organization.

Dr. Matthew Levine

Read More

One of our great strengths is our diversity: our growing AACE community represents a huge wealth and resource of people of diverse backgrounds.

Dr. Leslie Eldeiry

Read More

I am excited about our AACE and the place for clinical endocrinology in tomorrow’s health care ecosphere.

Dr. Sethu Reddy

Read More